Part 1 of 2
“Part 1 of 2 LaughterinLight PhD is a biomedical researcher, immunologist
- Answering: Can you explain the difference between how COVID affects your immune system vs how HIV affects it? * Feb 2024”
Frontiers | Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
COVID-19 can cause a severe immune response known as a cytokine storm, leading to poor prognosis and potentially fatal outcomes.
The virus triggers excessive infiltration of immune cells, such as macrophages and T-helper 17 cells.
This is happening. Even in mild cases. My last infection in March my only symptoms were migraines. I had mild Covid and my CD8 T cells are hyper-activated and my CD4 are on the low end of normal
“This is happening. Even in mild cases. My last infection in March my only symptoms were migraines. I had mild Covid and my CD8 T cells are hyper-activated and my CD4 are on the low end of normal”
A ji ljm sq ij
accelerated immunosenescence in CD4 and especially CD8 T-cell compartments may represent a common and unique outcome of SARS-CoV2 infection", not seen in the flu-like illnesses analysed in the same study
Over but not gone: lingering epigenetic effects of COVID-19
“Long COVID’ affects nearly one in five adults who have had coronavirus disease 2019 (COVID-19), yet the mechanisms underlying this disorder remain poorly understood. In a new study, Cheong et al. show that the epigenetic and transcriptional state of myeloid immune cells and their progenitors are durably altered in patients following severe COVID-19.”
"Long COVID, or post-acute COVID syndrome (PACS), is now estimated to occur in 19% of adults having presented with COVID-19..
“Long COVID, or post-acute COVID syndrome (PACS), is now estimated to occur in 19% of adults having presented with COVID-19.. PACS is believed to be caused by immunological changes that persist after acute infection. Furthermore, it is now increasingly recognized that these changes include not only those in the adaptive immune system, such as production of autoantibodies or autoreactive T cells due to molecular mimicry, but also those in the innate immune system.. A new study by Cheong et al. in Cell reveals crucial differences in the transcriptional and epigenetic state of innate immune cells and their progenitors [among PASC patients].. the study team demonstrated that myeloid cells and hematopoietic progenitor cells harbored transcriptional and chromatin accessibility changes that did not return to baseline even 1 year after acute SARS-CoV-2 infection. These data provide powerful evidence that persistent changes (i.e., trained immunity) may underlie PACS..”